Clinical and basic renal research, commentaries, The Renal Consult, Nephrology sans Frontieres, minireviews, reviews, Nephrology Images, Journal Club. Published weekly online and twice a month in print.doi:10.1038/ki.2009.180Winearls, Christopher G.Glassock, Richard J.Kidney International...
Response to 'Dividing stage 3 of chronic kidney disease (CKD): 3A and 3B' 来自 学术范 喜欢 0 阅读量: 15 作者:CG Winearls,RJ Glassock 摘要: Kidney International aims to inform the renal researcher and practicing nephrologists on all aspects of renal research. Clinical and basic renal ...
Over the past five years there have been dramatic changes to the way in which people with chronic kidney disease (CKD) are being managed in primary care. As a result of policy changes there are now many more people with CKD being identified, especially those with stage 3A. This article dea...
Dividing stage 3 of chronic kidney disease (CKD): 3A and 3B. Kirsztajn Gianna Mastroianni,Suassuna Jose H R,Bastos Marcus G. Kidney International . 2009Kirsztajn GM, Suassuna JH, Bastos MG. Dividing stage 3 of chronic kidney disease (CKD): 3A and 3B. Kidney Int. 2009;76(4):462-463...
Chronic kidney disease (CKD) is becoming increasingly prevalent among many different populations all over the world, including the US and Europe. Its multi... D Munikrishnappa - 《Aging Male》 被引量: 24发表: 2007年 Which patients with chronic kidney disease have the greatest symptom burden?
Stage 3a CKDeGFRAlbuminuriaBackground Estimated glomerular filtration rate (eGFR) is the sole diagnostic criterion for stage 3a chronic kidney disease (CKD). Because eGFR decreases with age, its prognostic utility in the elderly is controversial. Albuminuria is an important prognostic factor. To ...
Combined application of eGFR and albuminuria for the precise diagnosis of stage 2 and 3a CKD in the elderly. J Nephrol 2014; 27:289 -97.Conghui, LiuHaiping, ChenCuiyun, LiuChen, FuHui, ZhangHuayu, YangPeng, WangFan, WangShujun, ChenQing, Ma. (2014) Combined application of eGFR and ...
not address morbidities associated with CKD.?Sodium/glucose cotransporter 2 (SGLT2) inhibitors offer potential benefits to patients with diabetes and CKD, but their effectiveness may be diminished with decreased kidney function. We aimed to evaluate the safety and effectiveness of bexagliflozin, a ...
Max PlischkeMaria KohlLise BankirSascha ShayganfarAmmon HandisuryaGeorg HeinzeMartin Haas
were used to evaluate potential risk factors. Based on the results, the top five important variables, namely BUN, SBP, Right Intraocular Pressure (R-IOP), RBCs, and T-Cho/HDL-C (C/H), were identified as significant variables for evaluating the subjects with MetS and CKD stage 3a or 3b...